Globus Medical Debt to Equity Ratio 2010-2018 | GMED
Current and historical debt to equity ratio values for Globus Medical (GMED) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Globus Medical debt/equity for the three months ending September 30, 2018 was 0.00.
| Globus Medical Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2018-09-30 | $0.00B | $1.14B | 0.00 |
| 2018-06-30 | $0.00B | $1.10B | 0.00 |
| 2018-03-31 | $0.00B | $1.03B | 0.00 |
| 2017-12-31 | $0.00B | $0.97B | 0.00 |
| 2017-09-30 | $0.00B | $0.94B | 0.00 |
| 2017-06-30 | $0.00B | $0.91B | 0.00 |
| 2017-03-31 | $0.00B | $0.87B | 0.00 |
| 2016-12-31 | $0.00B | $0.83B | 0.00 |
| 2016-09-30 | $0.00B | $0.81B | 0.00 |
| 2016-06-30 | $0.00B | $0.78B | 0.00 |
| 2016-03-31 | $0.00B | $0.75B | 0.00 |
| 2015-12-31 | $0.00B | $0.72B | 0.00 |
| 2015-09-30 | $0.00B | $0.67B | 0.00 |
| 2015-06-30 | $0.00B | $0.64B | 0.00 |
| 2015-03-31 | $0.00B | $0.61B | 0.00 |
| 2014-12-31 | $0.00B | $0.59B | 0.00 |
| 2014-09-30 | $0.00B | $0.55B | 0.00 |
| 2014-06-30 | $0.00B | $0.53B | 0.00 |
| 2014-03-31 | $0.00B | $0.50B | 0.00 |
| 2013-12-31 | $0.00B | $0.47B | 0.00 |
| 2013-09-30 | $0.00B | $0.45B | 0.00 |
| 2013-06-30 | $0.00B | $0.42B | 0.00 |
| 2013-03-31 | $0.00B | $0.41B | 0.00 |
| 2012-12-31 | $0.00B | $0.39B | 0.00 |
| 2012-09-30 | $0.00B | $0.36B | 0.00 |
| 2012-06-30 | $0.00B | $0.32B | 0.00 |
| 2012-03-31 | $0.00B | $0.30B | 0.00 |
| 2011-12-31 | $0.00B | $0.28B | 0.00 |
| 2011-09-30 | $0.00B | $0.00B | 0.00 |
| 2011-06-30 | $0.00B | $0.00B | 0.00 |
| 2011-03-31 | $0.00B | $0.00B | 0.00 |
| 2010-12-31 | $0.00B | $0.23B | 0.00 |
| 2009-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $4.688B | $0.636B |
| Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products address a broad range of spinal fusion surgical procedures. Its disruptive technology products include minimally invasive surgical, motion preservation and advanced biomaterials technologies. Globus Medical, Inc. is based in Audubon, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $101.538B | 22.68 |
| Intuitive Surgical (ISRG) | United States | $62.929B | 59.23 |
| Edwards Lifesciences (EW) | United States | $36.708B | 37.59 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $24.505B | 16.57 |
| IDEXX Laboratories (IDXX) | United States | $18.185B | 49.52 |
| ABIOMED (ABMD) | United States | $16.332B | 107.81 |
| Hologic (HOLX) | United States | $13.523B | 20.45 |
| Teleflex (TFX) | United States | $13.173B | 29.90 |
| DexCom (DXCM) | United States | $12.930B | 0.00 |
| Varian Medical Systems (VAR) | United States | $12.041B | 30.08 |
| STERIS (STE) | United Kingdom | $10.392B | 26.71 |
| Masimo (MASI) | United States | $6.825B | 44.26 |
| Penumbra (PEN) | United States | $5.141B | 310.42 |
| LivaNova (LIVN) | United Kingdom | $4.861B | 31.20 |
| Integra LifeSciences Holdings (IART) | United States | $4.423B | 21.55 |
| Wright Medical Group (WMGI) | Netherlands | $3.941B | 0.00 |
| Cantel Medical (CMD) | United States | $3.599B | 35.50 |
| Inogen (INGN) | United States | $3.000B | 64.75 |
| Tandem Diabetes Care (TNDM) | United States | $2.811B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.761B | 23.10 |
| Glaukos (GKOS) | United States | $2.420B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $2.365B | 21.31 |
| OPKO Health (OPK) | United States | $1.612B | 0.00 |
| Nevro (NVRO) | United States | $1.461B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.358B | 216.18 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.244B | 35.93 |
| Accelerate Diagnostics (AXDX) | United States | $1.166B | 0.00 |
| Luminex (LMNX) | United States | $1.161B | 53.14 |
| CryoLife (CRY) | United States | $1.098B | 118.84 |
| Pacific Biosciences Of California (PACB) | United States | $1.088B | 0.00 |
| Intersect ENT (XENT) | United States | $1.039B | 0.00 |
| Natus Medical (BABY) | United States | $0.943B | 19.67 |
| Mesa Laboratories (MLAB) | United States | $0.900B | 36.80 |
| AngioDynamics (ANGO) | United States | $0.871B | 28.24 |
| ViewRay (VRAY) | United States | $0.791B | 0.00 |
| Veracyte (VCYT) | United States | $0.771B | 0.00 |
| AxoGen (AXGN) | United States | $0.677B | 0.00 |
| TransEnterix (TRXC) | United States | $0.653B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.640B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.488B | 0.00 |
| Si-Bone (SIBN) | United States | $0.466B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.457B | 0.00 |
| Accuray (ARAY) | United States | $0.454B | 0.00 |
| Fluidigm (FLDM) | United States | $0.424B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.377B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.344B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.324B | 0.00 |
| Neuronetics (STIM) | United States | $0.310B | 0.00 |
| Sientra (SIEN) | United States | $0.304B | 0.00 |
| IRadimed (IRMD) | United States | $0.292B | 62.14 |
| RTI Surgical (RTIX) | United States | $0.291B | 46.70 |
| Corindus Vascular Robotics (CVRS) | United States | $0.251B | 0.00 |
| Nuvectra (NVTR) | United States | $0.250B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.234B | 40.63 |
| Helius Medical Technologies (HSDT) | United States | $0.173B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.163B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.126B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.120B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.093B | 0.00 |
| ConforMIS (CFMS) | United States | $0.089B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.087B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.083B | 0.00 |
| EDAP TMS (EDAP) | France | $0.081B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.081B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.068B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.061B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.057B | 0.00 |
| Vermillion (VRML) | United States | $0.054B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.050B | 0.00 |
| Electromed (ELMD) | United States | $0.047B | 24.13 |
| Xtant Medical Holdings (XTNT) | United States | $0.045B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.039B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.034B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.033B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.027B | 0.00 |
| PAVmed (PAVM) | United States | $0.026B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.025B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.023B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.022B | 0.00 |
| Neovasc (NVCN) | Canada | $0.019B | 0.00 |
| Dynatronics (DYNT) | United States | $0.018B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.015B | 47.67 |
| American Shared Hospital Services (AMS) | United States | $0.015B | 11.13 |
| Nanovibronix (NAOV) | United States | $0.012B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.012B | 0.00 |
| Avinger (AVGR) | United States | $0.011B | 0.00 |
| Presbia (LENS) | Ireland | $0.009B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.009B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| InspireMD (NSPR) | Israel | $0.008B | 0.00 |
| Micron Solutions (MICR) | United States | $0.007B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
